Association of American Cancer Institutes Webinar: Paradigm Health presents on FDA's Real-Time Clinical Trials Initiative

Date and Time: September 28, 11am-12pm ET, virtual

Title: Pioneering a Modern Regulatory Framework: A Discussion with the Leaders Behind FDA’s Real-Time Clinical Trials

Participant Names:

Ivy Altomare, MD, VP, Clinical Research, Paradigm Health - moderator
Jeremy Walsh, Former Chief AI Officer, U.S. FDA - panelist
Emma Meagher, MD, Professor, Medicine and Pharmacology, Senior Vice Dean, Clinical and Translational Research, Perelman School of Medicine, University of Pennsylvania - panelist
Kent Thoelke, Founder and CEO, Paradigm Health - panelist

In April 2026, the FDA announced a landmark initiative to implement and evaluate a new model for clinical trial execution and regulatory review called Real-Time Clinical Trials. The model automates data collection and analysis and streamlines reporting of key safety and efficacy signals in near real time to trial sponsors and the FDA. In this webinar, the pioneers at the center of the FDA’s proof-of-concept trials from FDA, Paradigm Health and the University of Pennsylvania will discuss how the collaboration came together, what this initiative represents for clinical development and researchers, and why health systems and patients stand to benefit the most.

‍